“Bard” Glidepath Long-Term Hemodialysis Catheter - Taiwan Registration d77ec6c5f11dd26cc0d0c2931f67daf1
Access comprehensive regulatory information for “Bard” Glidepath Long-Term Hemodialysis Catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number d77ec6c5f11dd26cc0d0c2931f67daf1 and manufactured by BARD ACCESS SYSTEMS, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
d77ec6c5f11dd26cc0d0c2931f67daf1
Ministry of Health Medical Device Import No. 033814
DHA05603381403
Product Details
For details, it is Chinese approved copy of the imitation order
H Gastroenterology-urology devices
H5540 Blood access devices and accessories
Imported from abroad
Dates and Status
Jul 25, 2020
Jul 25, 2025

